| scholarly article | Q13442814 |
| P50 | author | Dae Won Jun | Q38360840 |
| P2093 | author name string | Sang Bong Ahn | |
| Sanghyun Lim | |||
| Myung-Jun Chung | |||
| Bo-Kyeong Kang | |||
| Jong Hyun Lim | |||
| P2860 | cites work | Probiotics modulate intestinal expression of nuclear receptor and provide counter-regulatory signals to inflammation-driven adipose tissue activation | Q27327276 |
| Oral Administration of Faecalibacterium prausnitzii Decreased the Incidence of Severe Diarrhea and Related Mortality Rate and Increased Weight Gain in Preweaned Dairy Heifers | Q28603476 | ||
| Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial) | Q30413592 | ||
| VSL#3 resets insulin signaling and protects against NASH and atherosclerosis in a model of genetic dyslipidemia and intestinal inflammation | Q34428997 | ||
| Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy | Q34574682 | ||
| Effects of probiotic yogurt consumption on metabolic factors in individuals with nonalcoholic fatty liver disease. | Q51314396 | ||
| Bifidobacterium longum with fructo-oligosaccharides in patients with non alcoholic steatohepatitis. | Q51368607 | ||
| Liver Steatosis Assessed by Controlled Attenuation Parameter (CAP) Measured with the XL Probe of the FibroScan: A Pilot Study Assessing Diagnostic Accuracy. | Q51714520 | ||
| Faecalibacterium prausnitzii phylotypes in type two diabetic, obese, and lean control subjects. | Q53129726 | ||
| Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study | Q57157097 | ||
| Optimal cutoff value for assessing changes in intrahepatic fat amount by using the controlled attenuation parameter in a longitudinal setting | Q61447186 | ||
| Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial | Q82112174 | ||
| Probiotic-Induced Priming of Innate Immunity to Protect Against Rotaviral Infection | Q87105804 | ||
| Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease | Q87406034 | ||
| The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota | Q35850620 | ||
| Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: a randomized controlled trial | Q36105168 | ||
| Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials | Q36762917 | ||
| Intra- and inter-examination repeatability of magnetic resonance spectroscopy, magnitude-based MRI, and complex-based MRI for estimation of hepatic proton density fat fraction in overweight and obese children and adults | Q36762955 | ||
| Unraveling mechanisms of action of probiotics. | Q37401581 | ||
| Inter-examination precision of magnitude-based MRI for estimation of segmental hepatic proton density fat fraction in obese subjects. | Q37698995 | ||
| Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease | Q38358419 | ||
| Interexamination repeatability and spatial heterogeneity of liver iron and fat quantification using MRI-based multistep adaptive fitting algorithm | Q38446344 | ||
| Effect of Lactobacillus gasseri SBT2055 in fermented milk on abdominal adiposity in adults in a randomised controlled trial | Q39122523 | ||
| Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics-based approach | Q39877262 | ||
| Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease | Q40444861 | ||
| Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH. | Q43414787 | ||
| Quantitative differences in intestinal Faecalibacterium prausnitzii in obese Indian children. | Q43573477 | ||
| Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations | Q46078112 | ||
| Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study | Q46680959 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | placebo | Q269829 |
| liver disease | Q929737 | ||
| fatty liver disease | Q6058862 | ||
| metabolic dysfunction–associated steatotic liver disease | Q1546498 | ||
| probiotics | Q1816730 | ||
| P304 | page(s) | 5688 | |
| P577 | publication date | 2019-04-05 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Randomized, Double-blind, Placebo-controlled Study of a Multispecies Probiotic Mixture in Nonalcoholic Fatty Liver Disease | |
| P478 | volume | 9 |
| Q90618587 | Effects of probiotics on nonalcoholic fatty liver disease: a systematic review and meta-analysis |
| Q91655107 | Efficacy of different probiotic protocols in irritable bowel syndrome: A network meta-analysis |
| Q90290407 | Gut Dysfunction and Non-alcoholic Fatty Liver Disease |
| Q92154626 | Nonalcoholic Fatty Liver Disease: A Challenge from Mechanisms to Therapy |
| Q92307491 | Systematic Review with Meta-Analysis: The Effects of Probiotics in Nonalcoholic Fatty Liver Disease |
Search more.